Prophylactic Octreotide to Prevent Post Duodenal EMR and Ampullectomy Bleeding

Summary

Our hypothesis is that prophylactic administration of 5 days of Octreotide following EMR or ampullectomy in patients with duodenal and ampullary adenomas greater than or equal to 10mm.

Timeline

Start

2014-03

Primary completion

2018-06-28

Completion

2020-07-06

Drugs

Indications